- Visibility 85 Views
- Downloads 33 Downloads
Emergence of Colistin Resistant Gram Negative Bacilli, in a Tertiary Care Rural Hospital from Western India
- Author Details:
-
Satyajeet Krishnarao Pawar
-
Geeta Satish Karande
-
Ravindra Vasantrao Shinde
-
Vaishali Satyajeet Pawa
Background: Colistin is one of the last resort of antibiotics used specifically in the treatment of multidrug resistant gram negative bacilli. Though an older class of antibiotic with no use in last four decades, resurgence of colistin use is also causing emergence of colistin resistant gram negative bacilli.
Objective: The aim of study was to find prevalence of colistin resistance and antibiotic susceptibility pattern of these colistin resistant strains isolated from different clinical specimens in a tertiary care hospital.
Methods: The study included clinical specimens received from wards and Intensive Care Units (ICUs), during January 2015 to December 2015. The specimens were processed by standard method, bacteria were identified by VITEK 2 compact (Biomerieux, France) automation system and antimicrobial susceptibility testing was done with the same system to detect MIC for penicillins, β-lactam/ β-lactamase inhibitor, cephalosporins, carbapenems, aminoglycosides, quinolones, folate inhibitors, glycicyclins and polymixins.
Results: Colistin resistance was observed in 9.98% of the clinical isolates. 51.81% of these colistin resistant strains were Pseudomonas spp. Tigecycline (41.50%) showed maximum sensitivity to colistin resistant strains.
Conclusion: Colistin resistance (9.98%) found in the study is quite alarming. A restricted and rational use of the colistin is the need of hour. A combination of colistin and tigecycline may be useful to prevent further rise of pan drug resistant bacteria.
Keywords: Colistin, MIC, MDR, Antibiotic, Antimicrobial Sensitivity Pattern
References
- Lim LM, Ly N, Anderson D, Yang JC, Macander L, Jarkowski A. et al,. Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing Pharmacotherapy. 2010;30(12):1279–1291.
- Talbot GH, Bradley J, Edwards J, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability task force of the Infectious Diseases Society of America. Clin Infect Dis. 2006;42:657–668.
- Li J, Nation RL, Turnidge JD,Milne RW,Coulthard K, Rayner CR et al. Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect Dis. 2006;6:589–601.
- Falagas ME, Kasiakou SK, Tsiodras S, Michalopoulos A. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Clin Med Res. 2006;4:138–146.
- Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant gram-negative bacteria. Int J Antimicrob Agents.2005;25:11–25.
- Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40:1333–1341.
- Pawar SK, Shinde RV, Patil HV, Patil SR, Karande GS, Mohite ST. Multidrug resistant gram negative bacilli in clinical isolates in a tertiary care hospital. Int J Health Sci Res. 2014;4(9):69-74.
- Ghafur A, Vidyalakshmi PR, Murali A, Priyadarshini K, Thirunarayan MA. Emergence of Pan-drug resistance Satyajeet Krishnarao Pawar et al. Emergence of Colistin Resistant Gram Negative Bacilli, in a Tertiary…. Indian J Microbiol Res 2016;3(3):308-313 313 amongst gram negative bacteria! The First case series from India. J Microbiol Infect Dis 2014;4(3):86-91.
- Falagas ME, Bliziotis IA. Pan drug-resistant Gram- negative bacteria: the dawn of the post- antibiotic era? Int J Antimicrob Agents 2007;29:630-636.
- Collee JG, Miles RS, Watt B, Tests for the identification of bacteria, In: Collee JG, Fraser AG, Marmion BP, Simmons A, Mackie and McCartney Practical Medical Microbiology.14th Ed. Churchill Livingstone, 1996:135-
- Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; CLSI document M100-S25.Wayne PA: Clinical and Laboratory Standards Institute; 2015.
- European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 2.0, valid from 2012-01-01. EUCAST: Clinical breakpoints www.eucast.org/clinical_breakpoints/.
- Cai Y, Chai D, Wang R, Liang B, Bai N. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother. 2012;67(7):1607-1615.
- Dhariwal AK, Tullu MS. Colistin: Re-emergence of the 'forgotten' antimicrobial agent. J Postgrad Med 2013;59:208-15.
- Dixon RA, Chopra I. Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide. Antimicrob Agents Chemother. 1986;29:781–788.
- Capone A, Giannellaa M, Fortini D, Giordanoc A, Meledandrid M, Ballardini M et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clinical Microbiology and Infection 2013;19(1):23–30.
- Taneja N, Singh G, Singh M, Sharma M. Emergence of Tigecycline & Colistin resistant Acinetobacter Baumanii in patients with complicated UTI in North India. Indian J Med Res. 2011;133:681-684.
- Wattal C, Goel N, Oberoi JK. Surveillance of Multidrug Resistant Organisms in a Tertiary Care Hospital in Delhi, India. J Assoc Physicians India 2010;58:S32-S36.
- Al-Sweih NA, Al-Hubail MA, Rotimi VO. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals. J Chemother 2011;23:13-16.
- Skov R, Monnet D. Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds. Euro Surveill. 2016; 21 (9):pii=30155. DOI: http://dx.doi.org/10.2807/1560-7917
[Google Scholar] ES.2016.21.9.30155. - Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016 Feb;16(2):161-8.
- Samonis G, Matthaiou DK, Kofteridis D, Maraki S, Falagas ME. In Vitro Susceptibility to Various Antibiotics of Colistin-Resistant Gram-Negative Bacterial Isolates in a General Tertiary Hospital in Crete, Greece. Clin Infect Dis 2010;50(12):1689–1691.
- Garbati MA, Abdulhak AB, Baba K, Sakkijha H. Infection due to colistin-resistant Enterobacteriacae in critically-ill patients. J Infect Dev Ctries 2013;7(10):713-
- Bowler PG, Duerden BI, Armstrong DG, Wound Microbiology and Associated Approaches to Wound Management. Clin Microbiol Rev. 2001 April 14(2):244-
- Chen S, Hu F, Zhang X, Xu X, Liu Y, Zhu D .Independent Emergence of Colistin -Resistant Enterobacteriaceae Clinical Isolates without Colistin Treatment. J Clinical Microbiol 2011;49(11):4022–4023.
- Marchaim D, Chopra T, Pogue JM, Perez F, Hujer AM et al, Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan. Antimicrob Agents Chemother. 2011;55(2);593–599.
How to Cite This Article
Vancouver
Pawar SK, Karande GS, Shinde RV, Pawa VS. Emergence of Colistin Resistant Gram Negative Bacilli, in a Tertiary Care Rural Hospital from Western India [Internet]. Indian J Microbiol Res. 2016 [cited 2025 Oct 09];3(3):308-313. Available from: https://doi.org/
APA
Pawar, S. K., Karande, G. S., Shinde, R. V., Pawa, V. S. (2016). Emergence of Colistin Resistant Gram Negative Bacilli, in a Tertiary Care Rural Hospital from Western India. Indian J Microbiol Res, 3(3), 308-313. https://doi.org/
MLA
Pawar, Satyajeet Krishnarao, Karande, Geeta Satish, Shinde, Ravindra Vasantrao, Pawa, Vaishali Satyajeet. "Emergence of Colistin Resistant Gram Negative Bacilli, in a Tertiary Care Rural Hospital from Western India." Indian J Microbiol Res, vol. 3, no. 3, 2016, pp. 308-313. https://doi.org/
Chicago
Pawar, S. K., Karande, G. S., Shinde, R. V., Pawa, V. S.. "Emergence of Colistin Resistant Gram Negative Bacilli, in a Tertiary Care Rural Hospital from Western India." Indian J Microbiol Res 3, no. 3 (2016): 308-313. https://doi.org/